EDITORIAL: SA belatedly joining vaccine programme is good news
Immunising part of the population is affordable, while SAA is costing the country R10.5bn
24 November 2020 - 20:37
After months of bad news on the coronavirus front, there is finally a ray of hope.
Initial results for three late-stage trials of experimental Covid-19 vaccines look better than expected: Pfizer and BioNTech say their shot is 95% effective, and Moderna’s candidate appears equally good. AstraZeneca and Oxford University say the efficacy of their vaccines range between 70% and 90%...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.